For much of 2020, the world waited with bated breath for the development of a COVID-19 vaccine. Now, with two vaccines approved for use by the FDA, attention is turning to rollout. Today, IMO is proud to announce the release of new value sets within our IMO Precision Sets suite that will help track and coordinate coronavirus vaccinations.
Big ideas. Better outcomes.
Fresh perspectives on clinical terminologies, code mapping, and patient insights from the experts at IMO.